![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 14315-14320, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
,
,
,
**,
,
,
§**§§, and
¶§§
From the
RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi, Yokohama 230-0045, Japan, the
§ Cellular Signaling Laboratory, RIKEN Harima Institute at
SPring-8, 1-1-1 Kohto, Mikazuki-cho, Sayo, Hyogo 679-5143, Japan, the
Cellular and Molecular Biology Laboratory, RIKEN, 2-1 Hirosawa,
Wako-shi, Saitama 351-0198, Japan, ¶ Core Research for Evolutional
Science and Technology (CREST), Japan Science and Technology
Corporation, 1637 Yana, Kisarazu, Chiba 292-0812, Japan, the
** Department of Biophysics and Biochemistry, Graduate School
of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo
113-0033, Japan, and 
Faculty of Medicine,
Kyoto University, Konoe Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Received for publication, June 20, 2001, and in revised form, January 11, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The Xrcc2 and Rad51D/Rad51L3 proteins,
which belong to the Rad51 paralogs, are required for homologous
recombinational repair (HRR) in vertebrates. The
Xrcc2 and Rad51D/Rad51L3 genes, whose products
interact with each other, have essential roles in ensuring normal
embryonic development. In the present study, we coexpressed the human
Xrcc2 and Rad51D/Rad51L3 proteins (Xrcc2 and Rad51D, respectively) in
Escher- ichia coli, and purified the Xrcc2·Rad51D complex to homogeneity. The Xrcc2·Rad51D complex catalyzed homologous pairing between single-stranded and double-stranded DNA, similar to the
function of the Xrcc3· Rad51C complex, which is another complex of
the Rad51 paralogs. An electron microscopic analysis showed that
Xrcc2·Rad51D formed a multimeric ring structure in the absence of
DNA. In the presence of ssDNA, Xrcc2·Rad51D formed a filamentous
structure, which is commonly observed among the human homologous
pairing proteins, Rad51, Rad52, and Xrcc3·Rad51C.
Chromosomal DNA is vulnerable to attacks from the environment and
sustains multiple types of damage, including the double strand
break (DSB),1 which is a
lethal DNA lesion for cells if it is not repaired. Homologous
recombinational repair (HRR) is one of the major pathways for the
repair of DSBs. When cells are defective in HRR, unrepaired DSBs
accumulate in chromosomes (1).
In Escherichia coli, the RecA protein catalyzes homologous
pairing, which is a key step in HRR (2, 3). In homologous pairing, RecA
binds the single-stranded DNA (ssDNA) produced at DSB sites and forms
nucleoprotein filaments. Then, the nucleoprotein filaments bind
double-stranded DNA (dsDNA) and form a three-component complex
that includes ssDNA, dsDNA, and RecA. In the three-component complex,
the homology between ssDNA and dsDNA is searched, and joint molecules,
in which the ssDNA invades into the homologous region of the dsDNA, are
formed as products of homologous pairing.
In eukaryotes, the Rad51 protein has been identified as a homologue of
RecA (4). The Rad51 protein, which is conserved from yeast to human
(5), forms a nucleoprotein filament that is strikingly similar to that
formed by RecA (6), suggesting their functional similarity in HRR.
Actually, the Saccharomyces cerevisiae and human Rad51
proteins (ScRad51 and HsRad51, respectively) catalyze homologous
pairing (7-9). We have found that the human Xrcc3 and Rad51C/Rad51L2
proteins (Xrcc3 and Rad51C, respectively) form a complex and catalyze
homologous pairing (10) in addition to HsRad51. Both Xrcc3 and Rad51C
are members of the Rad51 paralogs (Xrcc2 (11, 12), Xrcc3 (12, 13),
Rad51B/hREC2/Rad51L1 (14-16), Rad51C/Rad51L2 (17), and Rad51D/Rad51L3
(16, 18, 19), etc.) and share 20-30% amino acid identity with HsRad51.
The Xrcc2 and Xrcc3 genes were first identified
as human genes that complement the DNA damage-sensitive hamster cell
lines, irs1 and irs1SF, respectively (13, 20-23), and both genes were confirmed to be involved in HRR in vivo (24, 25). Cells
lacking Xrcc2 or Xrcc3 show extreme sensitivity to DNA cross-linking
reagents like cisplatin and ionizing radiation and have significantly
increased missegregation of chromosomes (12, 13, 26). Knock-out
experiments in the chicken DT40 cell lines showed that the
Rad51B/Rad51L1, Rad51C/Rad51L2, and
Rad51D/Rad51L3 genes, as well as the Xrcc2 and
Xrcc3 genes, are involved in the HRR pathway (27, 28). The
Xrcc2 protein also has homology to the S. cerevisiae Rad55 protein (29), which interacts with the S. cerevisiae Rad57
protein (30-32). Interestingly, the Xrcc2 knock-out mice
exhibited embryonic lethality associated especially with a high
frequency of apoptotic death of neurons in the developing brain (33).
Xrcc2 interacts with the human Rad51D/Rad51L3 protein (Rad51D), another
Rad51 paralog (34, 35). The Rad51D knock-out mice also
showed embryonic lethality (36), indicating that both Xrcc2 and Rad51D
are essential for embryonic development.
In the present study, we purified the Xrcc2·Rad51D complex and
characterized it biochemically. The purified Xrcc2·Rad51D complex catalyzed homologous pairing between ssDNA and dsDNA, similar to that
of the Xrcc3·Rad51C complex. The Xrcc2·Rad51D complex formed a
multimeric ring structure in the absence of DNA and formed nucleoprotein filaments in the presence of ssDNA. These biochemical characteristics of Xrcc2·Rad51D are consistent with the idea that these proteins act in an early step of the HRR pathway.
Proteins--
The Xrcc2 and Rad51D genes
were cloned from human brain cDNA (purchased from
CLONTECH) by PCR. The overexpression plasmid for
Xrcc2 and Rad51D was introduced into E. coli JM109(DE3)
cells with the plasmid containing the genes for E. coli tRNA
Arg-3 and tRNA Arg-4, which recognize the CGG and AGA/AGG codons,
respectively. The cells were grown in 10 liters of LB medium containing
100 µg/ml ampicillin and 34 µg/ml chloramphenicol at 30 °C for
10 h, and then 200 µM isopropyl
Oligonucleotides--
High pressure liquid
chromatography-purified oligonucleotides (120 mer) for the D-loop
formation assay were purchased from Roche Molecular Biochemicals. The
nucleotide sequences are as follows: 5'-ATTTC TTCAT TTCAT GCTAG ACAGA
AGAAT TCTCA GTAAC TTCTT TGTGC TGTGT GTATT CAACT CACAG AGTGG AACGT CCCTT
TGCAC AGAGC AGATT TGAAA CACTC TTTTT GTAGT-3' and were derived from a
clone of human Preparation of Closed Circular Double-stranded DNA--
To avoid
irreversible denaturation of the dsDNA, we prepared plasmid DNA without
any treatment that would potentially cause denaturation, such as
alkaline treatment. The plasmid DNA (pGsat4; 3216 base pairs)
containing the human Preparation of Circular Single-stranded DNA--
The
E. coli cells (JM109) containing pGsat4 DNA were cultured in
LB medium until an A660 of 0.3 was achieved and
were infected with the helper phage R408 at a multiplicity of infection
of ~20. After infection, the cells were continuously cultured for
6 h with vigorous agitation. Then, the supernatant was harvested
and treated with DNase I (10 unit/ml) and RNase A (10 µg/ml) for 15 min at 37 °C. The phage containing pGsat4 ssDNA was precipitated by
adding 0.25 volume of phage precipitation solution containing 3.75 M ammonium acetate (pH 7.5) and 20% polyethylene glycol
8000. The resulting pellet was resuspended with TE buffer, and the
pGsat4 ssDNA was extracted by chloroform:isoamyl alcohol (24:1)
followed by phenol:chloroform saturated with TE buffer. After several
phenol:chloroform extractions, the aqueous phase was extracted by
chloroform, and the pGsat4 ssDNA was precipitated with 2 volumes of
ethanol in the presence of 3.25 M ammonium acetate. The
resulting pellet was rinsed with 70% ethanol and dried under vacuum.
The pGsat4 ssDNA was dissolved in H2O; its concentration is
expressed in moles of nucleotides.
Single-stranded DNA Binding Assay--
Single-stranded pGsat4
DNA (30 µM) was mixed with Xrcc2·Rad51D in 10 µl of
standard reaction buffer containing 20 mM Tris-HCl (pH
8.1), 2 mM ATP, 1 mM dithiothreitol, 100 µg/ml BSA, 2 mM MgCl2, and 3% glycerol. The
reaction mixtures were incubated at 37 °C for 10 min and then
analyzed by 0.8% agarose gel electrophoresis in 0.5× TBE buffer. The
bands were visualized by ethidium bromide staining.
Double-stranded DNA Binding Assay--
Superhelical pGsat4 DNA
(18 µM, 3216 base pairs) was mixed with Xrcc2·Rad51D in
10 µl of standard reaction buffer containing 20 mM
Tris-HCl (pH 8.1), 2 mM ATP, 20 mM creatine
phosphate, 1 mM dithiothreitol, 100 µg/ml BSA, 12 units/ml creatine phosphokinase, 2 mM MgCl2,
and 6% glycerol. The reaction mixtures were incubated at 37 °C for
10 min, and the samples were electrophoresed on an 0.8% agarose gel
for 4 h at 3 V/cm in 0.5× TBE buffer. The bands were visualized
by ethidium bromide staining.
Assay for Homologous Pairing of ssDNA and dsDNA--
A
32P-labeled single-stranded 120 mer oligonucleotide (1.8 µM) was mixed with Xrcc2·Rad51D (2 µM) in
10 µl of standard reaction buffer containing 50 mM
Tris-HCl (pH 8.0), 2 mM ATP, 20 mM creatine phosphate, 1 mM dithiothreitol, 100 µg/ml BSA, 12 units/ml creatine phosphokinase, and 2 mM
MgCl2. The mixtures were incubated at 37 °C for 5 min,
and the reaction was started by the addition of pGsat4 form I DNA (20 µM). After an incubation at 37 °C for the indicated
time, the reaction was terminated by the addition of 0.5% sodium
dodecyl sulfate (SDS), and the proteins were removed from the
DNA by treatment with proteinase K (700 µg/ml) followed by an
incubation at 37 °C for 15 min. The products of homologous pairing
(D-loops) were separated from the unreacted DNA substrates by 0.8%
agarose gel electrophoresis in 0.5× TBE buffer. The amount of labeled
ssDNA fragments incorporated into the D-loops was quantified with a
Fuji BAS2500 image analyzer. The reactions were conducted with a
4.8-fold excess amount of ssDNA (molecule).
In the experiments with RecA, a 32P-labeled single-stranded
120 mer oligonucleotide (1.8 µM) was mixed with RecA (2 µM) in 10 µl of standard reaction buffer containing 50 mM Tris-HCl (pH 8.0), 20 mM creatine phosphate,
1 mM dithiothreitol, 100 µg/ml BSA, 12 units/ml creatine
phosphokinase, and 10 mM MgCl2 in the presence or absence of 2 mM ATP. The mixtures were incubated at
37 °C for 5 min, and the reaction was started by the addition of
pGsat4 form I DNA (20 µM). After an incubation at
37 °C for 10 min, the reaction was terminated, and the products were
separated from the unreacted DNA substrates by 0.8% agarose gel
electrophoresis in 0.5× TBE buffer. The amount of labeled ssDNA
fragments incorporated into the D-loops was quantified with a Fuji
BAS2500 image analyzer.
Electron Microscopy--
Xrcc2·Rad51D or HsRad51 (1-2
µM) was incubated with or without circular ssDNA
( Purification of the Xrcc2·Rad51D Complex--
Several splicing
variants of Rad51D have been reported in human cells (18). To identify
the Rad51D transcript that interacts with Xrcc2, we performed
two-hybrid screening with the human brain cDNA library. Two Rad51D
clones that positively interact with Xrcc2 were obtained. Both Rad51D
clones encode a protein consisting of 328 amino acid residues, which is
identical to HsR51H3 (Rad51D/Rad51L3) (16). We coexpressed Xrcc2 and
Rad51D in the E. coli recA The Xrcc2·Rad51D Complex Catalyzes D-loop Formation--
We have
previously reported that the Xrcc3·Rad51C complex catalyzes
homologous pairing between a single-stranded oligonucleotide and a
superhelical dsDNA by the D-loop formation assay, which is a standard
assay for homologous pairing by RecA (10). As shown in Fig.
2, the Xrcc2·Rad51D complex also
catalyzes homologous pairing. The superhelical dsDNA used in this assay
was prepared by a method without alkali treatment to avoid irreversible
denaturation of the double helix of the dsDNA (37). The homologous
pairing by Xrcc2·Rad51D was an ATP-independent reaction (Fig.
2A, lane 7), like those catalyzed by
Xrcc3·Rad51C (10), the human Rad52 protein (38, 39), and the E. coli RecT protein (40), and was detected only with a homologous
combination of ssDNA and dsDNA but not with a heterologous combination
or with BSA instead of Xrcc2·Rad51D (Fig. 2, A,
lane 6, and B, lane 1). The migration distance of the D-loop formed by Xrcc2·Rad51D was exactly the same as
that of the control D-loop formed by RecA (Fig. 2B,
lanes 3 and 4). These data clearly show that the
products formed by Xrcc2·Rad51D were authentic D-loops. A low
MgCl2 condition (2 mM) was preferred in the
homologous pairing promoted by Xrcc2·Rad51D as compared with a high
MgCl2 condition (10 mM) (Fig. 2B,
lanes 4 and 5), and the activity observed with
the low MgCl2 condition was about 20% of that observed
with RecA at its optimum MgCl2 condition (10 mM) (Fig. 2C).
Xrcc2·Rad51D Forms a Multimeric Ring Structure--
In the
Superdex 200HR gel filtration chromatography, Xrcc2·Rad51D was eluted
near the void volume, and no proteins were detected in the fractions
corresponding to the molecular size (71 kDa) of the
Xrcc2·Rad51D heterodimers (Fig. 3).
This result indicates that Xrcc2·Rad51D exists as a multimer rather
than a heterodimer. Therefore, we analyzed the structure of the
Xrcc2·Rad51D multimer by electron microscopy. As shown in Fig.
4, Xrcc2·Rad51D formed multimeric ring
structures (Fig. 4, A-E). The ring structure formed by
Xrcc2·Rad51D is similar to that of HsRad52 in its size and shape (39,
41).
Xrcc2·Rad51D Binds to DNA--
We tested the DNA binding
activity of Xrcc2·Rad51D. Xrcc2·Rad51D bound both ssDNA and dsDNA
(Fig. 5, A and B).
Although significant amounts of ssDNA and dsDNA were still bound to
Xrcc2·Rad51D in the absence of ATP, agarose gel electrophoresis
revealed that the migration distances of the complexes between
Xrcc2·Rad51D and DNA were drastically changed by the addition of ATP
(Fig. 5, A, lane 5, and B, lane
5). These results suggest that less Xrcc2·Rad51D bound to ssDNA
in the absence of ATP. Both Xrcc2 and Rad51D have an ATP-binding motif.
It has been reported that disruptions of the ATP-binding motif of Xrcc2
did not affect the complementation of the phenotypes of the
Xrcc2-deficient cell line, irs1 (42). The ATP may be important in
regulating the DNA binding of Rad51D or may bind different sites from
the ATP-binding motifs of Xrcc2 and Rad51D. Further studies are
required to elucidate the roles of ATP binding by Xrcc2·Rad51D.
Xrcc2·Rad51D Forms a Filamentous Complex with ssDNA--
In the
absence of DNA, Xrcc2·Rad51D formed a multimeric ring structure (Fig.
4), and no filamentous structure was observed. However, an electron
microscopic analysis showed that Xrcc2·Rad51D formed filamentous
structures in the presence of ssDNA (Fig.
6A). To compare the
Xrcc2·Rad51D filament with the HsRad51 filament, we visualized the
HsRad51·ssDNA complex under the same conditions (Fig. 6B)
used for the Xrcc2·Rad51D filament observation. As shown in Fig.
6B, HsRad51 formed short nucleoprotein filaments with ssDNA,
but the length of the filaments were shorter than that of the
Xrcc2·Rad51D filament, which fully covered circular ssDNA (Fig.
6A). The ssDNA circle (5386 bases) covered with
Xrcc2·Rad51D was significantly smaller than the same length of the
dsDNA circle (5386 base pairs) covered by HsRad51 (Fig. 6, A
and C). Thus, the DNA bound to Xrcc2·Rad51D may be
packaged differently from that bound to HsRad51, possibly wrapping
around the Xrcc2·Rad51D ring as in the case of HsRad52 (43).
Although both HsRad51 and Xrcc2·Rad51D formed filamentous complexes
in the presence of ssDNA, the appearance of those filaments was
different. HsRad51 formed a nucleoprotein filament, which was clearly
helical in appearance (Fig. 6, B and C). This
helical filament is strikingly similar to that of RecA (44). In
contrast, the filaments formed by Xrcc2·Rad51D did not have a
RecA-like helical appearance (Fig. 6A) and interestingly,
did have significant similarities with those formed by Xrcc3·Rad51C
(10) or HsRad52 (39).
It has been reported that Xrcc2 is required for
embryonic neurogenesis (33). Both Xrcc2 and Xrcc3
are expressed in the brain (12), where the expression of
Rad51 is very low (5). Our present and previous two-hybrid
analyses have shown that Xrcc2 and Xrcc3 interact
with Rad51D and Rad51C, respectively, in the human brain cDNA library (10). These facts suggest that
Xrcc2·Rad51D and Xrcc3·Rad51C may have a specific function in the
brain. In nondividing neuronal cells, the homologous
chromosomes, not the sister chromatids, must be the templates for
homologous pairing, because the cells are arrested before DNA synthesis
(the G0 phase). Xrcc2·Rad51D and Xrcc3·Rad51C may have
a preference for homologous pairing between homologous chromosomes
rather than sister chromatids.
Both Xrcc2 and Xrcc3 are required independently for HRR in mammalian
cells, because no other proteins can complement their mutant
phenotypes. These facts suggest that Xrcc2· Rad51D and Xrcc3·Rad51C are functionally similar but have different roles in the
HRR pathway. Schild et al. (35) detected an indirect interaction between Xrcc2 and Rad51C by the three-hybrid system in the
presence of Rad51D, suggesting a weak interaction between Rad51C and
Xrcc2·Rad51D. This interaction may function to form a
multiprotein complex containing all four proteins onto the DSB site.
Recently, it was reported that Xrcc2·Rad51D interacts with Rad51B and
Rad51C, forming a complex distinct from that of Xrcc3·Rad51C (45,
46). Xrcc2·Rad51D may be a part of the complex containing Xrcc2,
Rad51B, Rad51C, and Rad51D. Further analyses are required to elucidate
the biological significance of these homologous pairing activities in
the human system.
The Xrcc2, Xrcc3, Rad51C, and
Rad51D genes are also expressed in dividing cells, where the
Rad51 expression is observed (12, 17, 19). Interestingly,
the mutant cell lines lacking one of the Xrcc2,
Xrcc3, Rad51C, and Rad51D genes
significantly attenuated the Rad51 assembly on chromosomes after
exposure to In addition to the similarity between Xrcc2·Rad51D and
Xrcc3·Rad51C, we also found significant similarity between
Xrcc2·Rad51D and HsRad52, an important protein in the HRR pathway.
HsRad52 is known to form a multimeric ring structure similar to that of Xrcc2·Rad51D (41). Furthermore, we found that HsRad52 also formed nucleoprotein filaments with ssDNA and catalyzed homologous pairing as
did Xrcc2·Rad51D and Xrcc3·Rad51C (10, 39). These results indicate that the characteristics of HsRad52 are similar to those of
the Rad51 paralogs, although HsRad52 lacks obvious sequence homology
with any of the Rad51 paralogs. The multiple homologous pairing
activities may be necessary to support the HRR pathway in human
chromosomes, which are more complex than those of bacteria and
unicellular organisms such as yeast.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-thiogalactopyranoside was added to induce protein expression. Xrcc2
and Rad51D were produced for 12 h at 18 °C in the presence of
isopropyl
-thiogalactopyranoside, and the cells were harvested. Both
Xrcc2 and Rad51D contain a His6 tag at the N terminus. The
cells producing Xrcc2 and Rad51D were resuspended in 20 ml of buffer
containing 20 mM sodium phosphate (pH 8.5) and 0.5 M NaCl and were disrupted by sonication. The samples were
centrifuged for 20 min at 30,000 × g, and the
supernatants were incubated with 4 ml of Ni-NTA-agarose (Qiagen) for
1 h at 4 °C. Then, the Xrcc2 and Rad51D-bound resin was packed
into a column and washed with 300 ml of buffer containing 20 mM Tris-HCl (pH 8.5), 30 mM imidazole, and 0.5 M NaCl. Subsequently, the resin was washed with 150 ml of
buffer containing 20 mM Tris-HCl (pH 8.5) and 30 mM imidazole. Xrcc2 and Rad51D were eluted by a gradient of
imidazole from 30 to 400 mM in 20 mM Tris-HCl
(pH 8.5). The samples eluted from the Ni-NTA column were applied
to a Mono-Q column (Amersham Biosciences) previously
equilibrated with buffer containing 20 mM Tris-HCl (pH
8.5), 2 mM dithiothreitol, and 10% glycerol. The proteins
were eluted by a gradient of NaCl from 0 to 1200 mM and
were dialyzed against a buffer containing 20 mM Tris-HCl
(pH 8.1), 2 mM dithiothreitol, and 10% glycerol. Xrcc2 and
Rad51D were further purified by gel filtration chromatography on
Superdex 200HR resin (Amersham Biosciences). The purified proteins were
stored in 20 mM Tris-HCl (pH 8.1), 5 mM
dithiothreitol, and 10% glycerol. The protein concentration was
determined by the Bio-Rad protein assay kit (Bio-Rad) using bovine
serum albumin (BSA) as the standard protein.
-satellite DNA. The 5' ends of the oligonucleotides
were labeled with T4 polynucleotide kinase (New England Biolabs) in the
presence of [
-32P]ATP. DNA concentrations are
expressed in moles of nucleotides.
-satellite sequence was introduced into the
E. coli DH5
strain, and the cells were cultured for 12 to
16 h at 37 °C. The cells were harvested, mildly disrupted with
0.5 mg/ml lysozyme and 0.1% sarkosyl, and centrifuged at 28,000 rpm
for 1 h. The supernatant containing the pGsat4 plasmid DNA was
extracted with phenol/chloroform three times, and the pGsat4 DNA in the
aqueous phase was precipitated by ethanol. The pellet was dissolved in
1 ml of TE buffer (10 mM Tris·HCl (pH 8.0), 1 mM EDTA) and treated with 0.15 mg/ml RNase A at 37 °C for 30 min. The pGsat4 DNA was purified by a 5-20% sucrose gradient centrifugation at 24,000 rpm for 18 h. DNA concentrations are expressed in moles of nucleotides.
X174; 10 µM) or nicked circular dsDNA (
X174; 10 µM) in buffer, containing 20 mM Tris-HCl (pH
8.1), 1 mM dithiothreitol, and 2 mM
MgCl2, in the presence or absence of 2 mM ATP.
The mixtures were incubated at 37 °C for 10 min and were adsorbed
onto a freshly glow-discharged carbon-coated grid. The proteins or the
protein-DNA complexes were visualized by negative staining with 2%
uranyl acetate.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
JM109(DE3) strain
as N-terminal His6-tagged (20 amino acid residues) proteins. It has been reported that chicken DT40 cells lacking either
the Xrcc2 or Rad51D gene were extremely sensitive
to cisplatinum, which induced intra- and interstrand DNA cross-inks
(28). As shown in Fig. 1, B
and C, the His6-tagged Xrcc2 and Rad51D proteins fully complemented the cisplatinum-sensitive phenotypes in the Xrcc2
/
and Rad51D
/
chicken DT40 cells,
respectively (Fig. 1, B and C), indicating that
the His6 tag did not affect the functions of these
proteins. After coexpression, both Xrcc2 and Rad51D were detected in
the soluble fraction and were coeluted from the Ni-NTA-agarose (Qiagen). The Xrcc2 and Rad51D proteins were further copurified by
Mono-Q (Amersham Biosciences) column chromatography and Superdex 200HR
gel filtration chromatography (Amersham Biosciences) (Fig. 1A, lane 2). These results indicate that Xrcc2
and Rad51D form a complex. Endonuclease and exonuclease activities were
not detected in the Xrcc2·Rad51D fractions with superhelical and
linearized dsDNAs as substrates (data not shown).

View larger version (14K):
[in a new window]
Fig. 1.
The purified Xrcc2·Rad51D complex.
A, the Xrcc2·Rad51D complex (2 µg) eluted from the
Mono-Q column was analyzed by 15-25% gradient SDS-polyacrylamide gel
electrophoresis (lane 2). Lane 1, molecular
size markers. The proteins were visualized by Coomassie
Brilliant Blue staining. B, complementation of cisplatinum
sensitivity in the Xrcc2 knock-out DT40 mutant by
overexpression of the His-tagged human Xrcc2 cDNA.
Closed circles and open circles are
Xrcc2
/
and wild type DT40 cells, respectively.
Closed triangles and closed squares are
experiments with two independent clones with the His-tagged Xrcc2
protein. C, complementation of cisplatinum sensitivity in
the Rad51D knock-out DT40 mutant by overexpression of the
His-tagged human Rad51D cDNA. Closed circles
and open circles are Rad51D
/
and wild type
DT40 cells, respectively. Closed triangles and closed
squares are experiments with two independent clones with the
His-tagged Rad51D protein.

View larger version (45K):
[in a new window]
Fig. 2.
Homologous pairing activity of the
Xrcc2·Rad51D complex. A, a 32P-labeled
single-stranded 120-mer oligonucleotide (1.8 µM) was
incubated with Xrcc2·Rad51D (2 µM, as heterodimers) in
the standard reaction mixture containing 2 mM
MgCl2 at 37 °C for 5 min, and the reactions were
initiated by the addition of pGsat4 form I DNA (20 µM).
The reaction times were 0 min (lane 1), 5 min (lane
2), 10 min (lane 3), 20 min (lane 4), and 40 min (lanes 5-7). Lane 6 is a control with a
heterologous combination of DNA substrates, and lane 7 is an
experiment without ATP. B, a 32P-labeled
single-stranded 120-mer oligonucleotide (1.8 µM) was
incubated with BSA (2 µM, lane 1), RecA (2 µM, lanes 2 and 3) or
Xrcc2·Rad51D (2 µM, as heterodimers, lanes 4 and 5) at 37 °C for 5 min, and the reactions were
initiated by the addition of pGsat4 form I DNA (20 µM).
The reaction time was 10 min. Lanes 1 and 5 show
experiments with 2 mM MgCl2, and lanes
2-4 show experiments with 10 mM MgCl2.
C, graphic representation of panel B. The
reactions were conducted with a 4.8-fold excess amount of ssDNA
(molecule); the percentage of D-loop formation was calculated relative
to the limiting amount of dsDNA. In the case of RecA, about 30% of the
dsDNA was converted into D-loops (lane 3). The amount of
D-loop formation relative to that formed by RecA is presented.
Lanes 1-5 correspond to the lane numbers in
B.

View larger version (27K):
[in a new window]
Fig. 3.
The Xrcc2·Rad51D complex was analyzed by
Superdex 200HR column chromatography. A, the elution
profile of the Xrcc2·Rad51D complex by Superdex 200HR column
chromatography. B, peak fractions were analyzed by 15-25%
gradient SDS-polyacrylamide gel electrophoresis. The proteins were
visualized by Coomassie Brilliant Blue staining.

View larger version (88K):
[in a new window]
Fig. 4.
Electron microscopic images of
Xrcc2·Rad51D. A-E, images of Xrcc2·Rad51D in the
absence of DNA. All images were photographed by negative staining with
uranyl acetate. The white and black bars denote
50 and 10 nm, respectively.
![]()
View larger version (14K):
[in a new window]
Fig. 5.
DNA binding activity of Xrcc2·Rad51D.
A, the dsDNA binding of Xrcc2·Rad51D. Superhelical pGsat4
DNA (18 µM, 3216 base pairs) was mixed with the indicated
amounts of Xrcc2·Rad51D in 10 µl of the standard reaction buffer.
The reaction mixtures were incubated at 37 °C for 10 min, and the
samples were analyzed by 0.8% agarose gel electrophoresis. The bands
were visualized by ethidium bromide staining. Lanes 1-4 are
experiments with ATP, and lane 5 is an experiment without
ATP. (B, single-stranded pGsat4 DNA (30 µM)
was mixed with Xrcc2·Rad51D in 10 µl of standard reaction buffer.
The reaction mixtures were incubated at 37 °C for 10 min and were
analyzed by 0.8% agarose gel electrophoresis. The bands were
visualized by ethidium bromide staining. Lanes 1-4 are
experiments with ATP, and lane 5 is an experiment without
ATP.

View larger version (84K):
[in a new window]
Fig. 6.
Nucleoprotein filament formation by
Xrcc2·Rad51D. A, electron microscopic images of
Xrcc2·Rad51D in the presence of ssDNA. The black bar
denotes 100 nm. Circular
X174 ssDNA (5386 bases) was used as a
template. B, electron microscopic images of HsRad51 in the
presence of ssDNA. The black bar denotes 100 nm. Circular
X174 ssDNA (5386 bases) was used as a template. C,
electron microscopic images of HsRad51 in the presence of dsDNA. The
black bar denotes 200 nm. Nicked circular
X174 dsDNA
(5386 base pairs) was used as a template. Images were photographed by
negative staining with uranyl acetate.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-rays (28, 47). These results suggest that
Xrcc2·Rad51D and Xrcc3·Rad51C are assembled on the damaged sites of
chromosomes before Rad51 and that they initiate homologous pairing in
cooperation with Rad51 in dividing cells.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Keiko Eda for technical assistance and to Drs. Naoshi Domae and Koji Takio for protein sequencing. We thank Drs. Shunichi Takeda (Kyoto University) and Minoru Takata (Kawasaki Medical School) for the in vivo analysis with chicken DT40 cells.
| |
FOOTNOTES |
|---|
* This work was supported in part by the Bioarchitect Research Program (RIKEN), Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST), and a grant-in-aid from the Ministry of Education, Sports, Culture, Science, and Technology, Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§§ To whom correspondence may be addressed. E-mail: yokoyama@biochem.s.u-tokyo.ac.jp or tshibata@postman.riken.go.jp.
Published, JBC Papers in Press, February 7, 2002, DOI 10.1074/jbc.M105719200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: DSB, double strand break; HRR, homologous recombinational repair; ssDNA, single-stranded DNA; dsDNA, double-stranded DNA; Ni-NTA, nickel-nitrilotriacetic acid; BSA, bovine serum albumin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Sonoda, E.,
Sasaki, M. S.,
Buerstedde, J.-M.,
Bezzubova, O.,
Shinohara, A.,
Ogawa, H.,
Takata, M.,
Yamaguchi-Iwai, Y.,
and Takeda, S.
(1998)
EMBO J.
17,
598-608[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Shibata, T.,
DasGupta, C.,
Cunningham, R. P.,
and Radding, C. M.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
1638-1642 |
| 3. |
McEntee, K.,
Weinstock, G. M.,
and Lehman, I. R.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
2615-2619 |
| 4. |
Shinohara, A.,
Ogawa, H.,
and Ogawa, T.
(1992)
Cell
69,
457-470[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Shinohara, A.,
Ogawa, H.,
Matsuda, Y.,
Ushio, N.,
Ikeo, K.,
and Ogawa, T.
(1993)
Nat. Genet.
4,
239-243[CrossRef][Medline]
[Order article via Infotrieve] |
| 6. |
Ogawa, T., Yu, X.,
Shinohara, A.,
and Egelman, E.
(1993)
Science
259,
1896-1899 |
| 7. |
Sung, P.
(1994)
Science
265,
1241-1243 |
| 8. |
Baumann, P.,
Benson, F. E.,
and West, S. C.
(1996)
Cell
87,
757-766[CrossRef][Medline]
[Order article via Infotrieve] |
| 9. |
Gupta, R. C.,
Bazemore, L. R.,
Golub, E. I.,
and Radding, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
463-468 |
| 10. |
Kurumizaka, H.,
Ikawa, S.,
Nakada, M.,
Eda, K.,
Kagawa, W.,
Takata, M.,
Takeda, S.,
Yokoyama, S.,
and Shibata, T.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
5538-5543 |
| 11. |
Cartwright, R.,
Tambini, C. E.,
Simpson, P. J.,
and Thacker, J.
(1998a)
Nucleic Acids Res.
26,
3084-3089 |
| 12. |
Liu, N.,
Lamerdin, J. E.,
Tebbs, R. S.,
Schild, D.,
Tucker, J.,
Shen, M. R.,
Brookman, K. W.,
Siciliano, M. J.,
Walter, C. A.,
Fan, W.,
Narayana, L. S.,
Zhou, Z.,
Adamson, A. W.,
Sorensen, K. J.,
Chen, D. J.,
Jones, N. J.,
and Thompson, L. H.
(1998)
Mol. Cell
1,
783-793[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Tebbs, R. S.,
Zhao, Y.,
Tucker, J. D.,
Scheerer, J. B.,
Siciliano, M. J.,
Hwang, M.,
Liu, N.,
Legerski, R. J.,
and Thompson, L. H.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6354-6358 |
| 14. |
Albala, J. S.,
Thelen, M. P.,
Prange, C.,
Fan, W.,
Christensen, M.,
Thompson, L. H.,
and Lennon, G. G.
(1997)
Genomics
46,
476-479[CrossRef][Medline]
[Order article via Infotrieve] |
| 15. |
Rice, C. M.,
Smith, S. T.,
Bullrich, F.,
Havre, P.,
and Kmiec, E. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7417-7422 |
| 16. |
Cartwright, R.,
Dunn, A. M.,
Simpson, P. J.,
Tambini, C. E.,
and Thacker, J.
(1998b)
Nucleic Acids Res.
26,
1653-1659 |
| 17. |
Dosanjh, M. K.,
Collins, D. W.,
Wufang, F.,
Lennon, G. G.,
Albala, J. S.,
Shen, Z.,
and Schild, D.
(1998)
Nucleic Acids Res.
26,
1179-1184 |
| 18. |
Kawabata, M.,
and Saeki, K.
(1999)
Biochem. Biophys. Res. Commun.
257,
156-162[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Pittman, D. L.,
Weinberg, L. R.,
and Schimenti, J. C.
(1998)
Genomics
49,
103-111[CrossRef][Medline]
[Order article via Infotrieve] |
| 20. |
Jones, N. J.,
Cox, R.,
and Thacker, J.
(1987)
Mutat. Res.
183,
279-286[Medline]
[Order article via Infotrieve] |
| 21. |
Fuller, L. F.,
and Painter, R. B.
(1988)
Mutat. Res.
193,
109-121[Medline]
[Order article via Infotrieve] |
| 22. |
Jones, N. J.,
Zhao, Y.,
Siciliano, M. J.,
and Thompson, L. H.
(1995)
Genomics
26,
619-622[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Thacker, J.,
Tambini, C. E.,
Simpson, P. J.,
Tsui, L. C.,
and Scherer, S. W.
(1995)
Hum. Mol. Genet.
4,
113-120 |
| 24. |
Johnson, R. D.,
Liu, N.,
and Jasin, M.
(1999)
Nature
401,
397-399[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Pierce, A. J.,
Johnson, R. D.,
Thompson, L. H.,
and Jasin, M.
(1999)
Genes Dev.
13,
2633-2638 |
| 26. |
Griffin, C. S.,
Simpson, P. J.,
Wilson, C. R.,
and Thacker, J.
(2000)
Nat. Cell Biol.
2,
757-761[CrossRef][Medline]
[Order article via Infotrieve] |
| 27. |
Takata, M.,
Sasaki, M. S.,
Sonoda, E.,
Fukushima, T.,
Morrison, C.,
Albala, J. S.,
Swagemakers, S. M. A.,
Kanaar, R.,
Thompson, L. H.,
and Takeda, S.
(2000)
Mol. Cell. Biol.
20,
6476-6482 |
| 28. |
Takata, M.,
Sakaki, M. S.,
Tachiiri, S.,
Fukushima, T.,
Sonoda, E.,
Schild, D.,
Thompson, L. H.,
and Takeda, S.
(2001)
Mol. Cell. Biol.
21,
2858-2866 |
| 29. |
Thacker, J.
(1999)
Trends Genet.
15,
166-168[CrossRef][Medline]
[Order article via Infotrieve] |
| 30. |
Hays, S. L.,
Firmenich, A. A.,
and Berg, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6925-6929 |
| 31. |
Johnson, R. D.,
and Symington, L. S.
(1995)
Mol. Cell. Biol.
15,
4843-4850[Abstract] |
| 32. |
Sung, P.
(1997)
Genes Dev.
11,
1111-1121 |
| 33. |
Deans, B.,
Griffin, C. S.,
Maconochie, M.,
and Thacker, J.
(2000)
EMBO J.
19,
6675-6685[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Braybrooke, J. P.,
Spink, K. G.,
Thacker, J.,
and Hickson, I. D.
(2000)
J. Biol. Chem.
275,
29100-29106 |
| 35. |
Schild, D.,
Lio, Y.,
Collins, D. W.,
Tsomondo, T.,
and Chen, D. J.
(2000)
J. Biol. Chem.
275,
16443-16889 |
| 36. |
Pittman, D. L.,
and Schimenti, J. C.
(2000)
Genesis
26,
167-173[CrossRef][Medline]
[Order article via Infotrieve] |
| 37. |
Shibata, T.,
Cunningham, R. P.,
and Radding, C. M.
(1981)
J. Biol. Chem.
256,
7557-7564 |
| 38. |
Kurumizaka, H.,
Aihara, H.,
Kagawa, W.,
Shibata, T.,
and Yokoyama, S.
(1999)
J. Mol. Biol.
291,
537-548[CrossRef][Medline]
[Order article via Infotrieve] |
| 39. |
Kagawa, W.,
Kurumizaka, H.,
Ikawa, S.,
Yokoyama, S.,
and Shibata, T.
(2001)
J. Biol. Chem.
276,
35201-35208 |
| 40. |
Noirot, P.,
and Kolodner, R. D.
(1998)
J. Biol. Chem.
273,
12274-12280 |
| 41. |
Stasiak, A. Z.,
Larquet, E.,
Stasiak, A.,
Muller, S.,
Engel, A.,
Van Dyck, E.,
West, S. C.,
and Egelman, E. H.
(2000)
Curr. Biol.
10,
337-340[CrossRef][Medline]
[Order article via Infotrieve] |
| 42. |
O'Regan, P.,
Wilson, C.,
Townsend, S.,
and Thacker, J.
(2001)
J. Biol. Chem.
276,
22148-22153 |
| 43. |
Parsons, C. A.,
Baumann, P.,
Van Dyck, E.,
and West, S. C.
(2000)
EMBO J.
19,
4175-4181[CrossRef][Medline]
[Order article via Infotrieve] |
| 44. |
Flory, J.,
Tsang, S. S.,
and Muniyappa, K.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
7026-7030 |
| 45. |
Masson, J.-Y.,
Tarsounas, M. C.,
Stasiak, A. Z.,
Stasiak, A.,
Shah, R.,
McIlwraith, M. J.,
Benson, F. E.,
and West, S. C.
(2001)
Genes Dev.
15,
3296-3307 |
| 46. |
Miller, K. A.,
Yoshikawa, D. M.,
McConnell, I. R.,
Clark, R.,
Schild, D.,
and Albala, J. S.
(2002)
J. Biol. Chem.
277,
8406-8411 |
| 47. |
Bishop, D. K.,
Ear, U.,
Bhattacharyya, A.,
Calderone, C.,
Beckett, M.,
Weichselbaum, R. R.,
and Shinohara, A.
(1998)
J. Biol. Chem.
273,
21482-21488 |
This article has been cited by other articles:
![]() |
C. Wiese, J. M. Hinz, R. S. Tebbs, P. B. Nham, S. S. Urbin, D. W. Collins, L. H. Thompson, and D. Schild Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination. Nucleic Acids Res., January 1, 2006; 34(9): 2833 - 2843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gruver, K. A. Miller, C. Rajesh, P. G. Smiraldo, S. Kaliyaperumal, R. Balder, K. M. Stiles, J. S. Albala, and D. L. Pittman The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C Mutagenesis, November 1, 2005; 20(6): 433 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yonetani, H. Hochegger, E. Sonoda, S. Shinya, H. Yoshikawa, S. Takeda, and M. Yamazoe Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage Nucleic Acids Res., August 10, 2005; 33(14): 4544 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Smiraldo, A. M. Gruver, J. C. Osborn, and D. L. Pittman Extensive Chromosomal Instability in Rad51d-Deficient Mouse Cells Cancer Res., March 15, 2005; 65(6): 2089 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Miller, J. M. Hinz, N.A. Yamada, L. H. Thompson, and J. S. Albala Nuclear localization of Rad51B is independent of Rad51C and BRCA2 Mutagenesis, January 1, 2005; 20(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Lio, D. Schild, M. A. Brenneman, J. L. Redpath, and D. J. Chen Human Rad51C Deficiency Destabilizes XRCC3, Impairs Recombination, and Radiosensitizes S/G2-phase Cells J. Biol. Chem., October 1, 2004; 279(40): 42313 - 42320. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Yan, M Wang, W J Lemon, and M You Single nucleotide polymorphism (SNP) analysis of mouse quantitative trait loci for identification of candidate genes J. Med. Genet., September 1, 2004; 41(9): e111 - e111. [Full Text] [PDF] |
||||
![]() |
K. S. Shim, C. Schmutte, G. Tombline, C. D. Heinen, and R. Fishel hXRCC2 Enhances ADP/ATP Processing and Strand Exchange by hRAD51 J. Biol. Chem., July 16, 2004; 279(29): 30385 - 30394. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, N. Sarai, W. Kagawa, R. Enomoto, T. Shibata, H. Kurumizaka, and S. Yokoyama Preferential binding to branched DNA strands and strand-annealing activity of the human Rad51B, Rad51C, Rad51D and Xrcc2 protein complex Nucleic Acids Res., May 11, 2004; 32(8): 2556 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ayora, B. Carrasco, E. Doncel, R. Lurz, and J. C. Alonso Bacillus subtilis RecU protein cleaves Holliday junctions and anneals single-stranded DNA PNAS, January 13, 2004; 101(2): 452 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, J.-Y. Masson, R. Shah, P. O'Regan, and S. C. West RAD51C Is Required for Holliday Junction Processing in Mammalian Cells Science, January 9, 2004; 303(5655): 243 - 246. [Abstract] [Full Text] [PDF] |
||||
|
|